Successful treatment of macrolide-resistant Mycobacterium abscessus infection using multi-drug regimens including dual β-lactams and phage therapy: case reports in two children
ASM Case Reports · 02.09.2025 · 1 (5)
DOI: 10.1128/asmcr.00087-24 ↗Kurz gefasst
Fallbericht in der Zeitschrift ASM Case Reports, erschienen am 02.09.2025. Verfasst von Masako Shimamura und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Infectious Diseases, Department of Pediatrics, Nationwide Children's Hospital and The Ohio State University, Columbus, Ohio, US…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Mycobacterium abscessus ( M. abscessus ) infections are poorly responsive to antibiotics, with lower rates of clinical and microbiological clearance for macrolide-resistant isolates compared to macrolide-susceptible strains. Successful treatment of macrolide-resistant M. abscessus infection has not been reported for children. Case Summary Here we report two children with macrolide-resistant M. abscessus infections who achieved clinical remission and microbiologic clearance using multi-drug treatment regimens including clofazimine, bedaquiline, linezolid or eravacycline, dual β-lactam therapy with meropenem and amoxicillin, and, in one case, phage therapy.
Conclusion
Successful treatment of macrolide-resistant M. abscessus infections in children can be achieved using multi-drug regimens including novel dual β-lactam combinations and phage therapy. Dose adjustment with therapeutic drug monitoring can ameliorate some drug-induced toxicities in children.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Infectious Diseases, Department of Pediatrics, Nationwide Children's Hospital and The Ohio State University, Columbus, Ohio, USA.
- Division of Infectious Diseases, Department of Pediatrics, University of Nebraska Medical Center, Omaha, Nebraska, USA.
- Clinical Pharmacy, Nationwide Children's Hospital, Columbus, Ohio, USA.
- Department of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Department of Internal Medicine and Infectious Diseases, Louis Stokes Cleveland VA Medical Center, Case Western Reserve University, Cleveland, Ohio, USA.
- Department of Internal Medicine, Case Western Reserve University-Louis Stokes Cleveland VA Medical Center, Center for Antimicrobial Resistance and Epidemiology (Case VA CARES), Cleveland, Ohio, USA.
ORCID-Profile: Masako Shimamura, Robert A Bonomo, Khalid M Dousa
Zitieren
APA
Shimamura, M., Becken, B., Tansmore, J., Cristinziano, M., Abad, L., Dedrick, R. M., Jacobs-Sera, D., Hatfull, G. F., Bonomo, R. A., & Dousa, K. M. (2025). Successful treatment of macrolide-resistant Mycobacterium abscessus infection using multi-drug regimens including dual β-lactams and phage therapy: case reports in two children. ASM Case Reports, 1(5). https://doi.org/10.1128/asmcr.00087-24
Vancouver
Shimamura M, Becken B, Tansmore J, Cristinziano M, Abad L, Dedrick RM, et al. Successful treatment of macrolide-resistant Mycobacterium abscessus infection using multi-drug regimens including dual β-lactams and phage therapy: case reports in two children. ASM Case Reports. 2025;1(5). doi:10.1128/asmcr.00087-24
BibTeX
@article{Shimamura2025,
author = {Shimamura, Masako and Becken, Bradford and Tansmore, Jessica and Cristinziano, Madison and Abad, Lawrence and Dedrick, Rebekah M and Jacobs-Sera, Deborah and Hatfull, Graham F and Bonomo, Robert A and Dousa, Khalid M},
title = {Successful treatment of macrolide-resistant Mycobacterium abscessus infection using multi-drug regimens including dual β-lactams and phage therapy: case reports in two children},
journal = {ASM Case Reports},
year = {2025},
volume = {1},
number = {5},
doi = {10.1128/asmcr.00087-24}
}
EUVIMED